Literature DB >> 444670

Principles of blood separation and component extraction in a disposable continuous-flow single-stage channel.

J P Hester, R M Kellogg, A P Mulzet, V R Kruger, K B McCredie, E J Freireich.   

Abstract

A single-stage disposable channel and seal that provides for leukocyte and granulocyte collection by continuous-flow cell separation (CFCS) has been designed by the IBM Corporation. This paper describes (1) the separation characteristics of whole blood as it responds to varying gravitational (G) forces and flow rates through the channel; (2) the mechanism by which the buffy coat accumulates and is extracted; (3) the efficiency of extraction; (4) those donor and procedural variables that contribute to the final yield; (5) posttransfusion increment response in patients; and (6) the functional integrity of the cells collected.

Entities:  

Mesh:

Year:  1979        PMID: 444670

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Canine lymphoma-associated antigens defined by murine monoclonal antibodies.

Authors:  Z Steplewski; K A Jeglum; C Rosales; N Weintraub
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Frequency of B-lymphocyte transformation by Epstein-Barr virus decreases with entry into the cell cycle.

Authors:  A J Roome; C L Reading
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

4.  Evidence that abnormal platelet functions in human Chédiak-Higashi syndrome are the result of a lack of dense bodies.

Authors:  F Rendu; J Breton-Gorius; M Lebret; C Klebanoff; D Buriot; C Griscelli; S Levy-Toledano; J P Caen
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.